National Cervical Screening Program Clinical Guidelines: Important Changes for Women at Intermediate Risk
In light of new evidence, changes to the NCSP’s Guidelines for the clinical management of women at intermediate risk came into effect on 1 February. This follows the Cancer Council Australia Clinical Guidelines review of national data from the renewed program. A review shows that women at i whose follow-up test is human papillomavirus (HPV) […]
COVID-19 Impacts on The National Cervical Screening Program
The Department of Health has provided revised guidelines for health care providers on managing cervical screening participants during the COVID-19 pandemic. Where possible The National Cervical Screening Program (the Program) is encouraging health care providers to continue to offer routine screening and follow-up. The Program recognises some providers/clinics may have different capabilities during the pandemic, […]